Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug

Full-Life Technologies gets $150M; Quince finds a new life; China biotech gets $50M; SERB Pharmaceuticals buys rights to Hansa Biopharma drug; and more

Raccontata daendpoints.news